Trial intelligence / Profile preview

INCLUSIVE: Irbesartan/HCTZ in Uncontrolled Hypertension

NCT00562809Phase 4Completed

Sponsor
Sanofi
Start
Jul 2003
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of irbesartan, hydrochlorothiazide in hypertension (HTN), sponsored by Sanofi. Started Jul 2003; status: completed.

02

Drugs

irbesartanhydrochlorothiazide
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00562809.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00562809.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call